Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Patsy G Oliver"'
Autor:
Praveen K Vayalil, Joo-Yeun Oh, Fen Zhou, Anne R Diers, M Ryan Smith, Hafez Golzarian, Patsy G Oliver, Robin A J Smith, Michael P Murphy, Sadanandan E Velu, Aimee Landar
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120460 (2015)
Despite advances in screening and treatment over the past several years, breast cancer remains a leading cause of cancer-related death among women in the United States. A major goal in breast cancer treatment is to develop safe and clinically useful
Externí odkaz:
https://doaj.org/article/12e59c8641af42228ba786a8797bd8f0
Autor:
Marie K. Kirby, Ryne C. Ramaker, Jason Gertz, Nicholas S. Davis, Bobbi E. Johnston, Patsy G. Oliver, Katherine C. Sexton, Edward W. Greeno, John D. Christein, Martin J. Heslin, James A. Posey, William E. Grizzle, Selwyn M. Vickers, Donald J. Buchsbaum, Sara J. Cooper, Richard M. Myers
Publikováno v:
Molecular Oncology, Vol 10, Iss 8, Pp 1169-1182 (2016)
Background Pancreatic adenocarcinoma patients have low survival rates due to late‐stage diagnosis and high rates of cancer recurrence even after surgical resection. It is important to understand the molecular characteristics associated with surviva
Externí odkaz:
https://doaj.org/article/18b28309935b4450822c1557f59a1f5b
Autor:
M. Ryan Smith, Praveen K. Vayalil, Fen Zhou, Gloria A. Benavides, Reena R. Beggs, Hafez Golzarian, Bhavitavya Nijampatnam, Patsy G. Oliver, Robin A.J. Smith, Michael P. Murphy, Sadanandan E. Velu, Aimee Landar
Publikováno v:
Redox Biology, Vol 8, Iss C, Pp 136-148 (2016)
Many cancer cells follow an aberrant metabolic program to maintain energy for rapid cell proliferation. Metabolic reprogramming often involves the upregulation of glutaminolysis to generate reducing equivalents for the electron transport chain and am
Externí odkaz:
https://doaj.org/article/28598c4d4dc14203b4dba36a2bf4aa84
Autor:
Donald J. Buchsbaum, Albert F. LoBuglio, Pablo Arnoletti, Patsy G. Oliver, Tong Zhou, Cecil R. Stockard, Jeffrey Sellers, William E. Grizzle, Wenquan Wang, Zhi Huang, Kurt R. Zinn, Selwyn M. Vickers, Leo Christopher DeRosier
Purpose: To evaluate agonistic TRA-8 monoclonal antibody to human death receptor 5 (DR5) and gemcitabine in vitro and in an orthotopic pancreatic cancer model. Experimental Design: Pancreatic cancer cell lines were screened for DR5 expression, cytoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40eae0569c48033139ebbfba43c63a09
https://doi.org/10.1158/1535-7163.c.6531299.v1
https://doi.org/10.1158/1535-7163.c.6531299.v1
Autor:
Donald J. Buchsbaum, Albert F. LoBuglio, Pablo Arnoletti, Patsy G. Oliver, Tong Zhou, Cecil R. Stockard, Jeffrey Sellers, William E. Grizzle, Wenquan Wang, Zhi Huang, Kurt R. Zinn, Selwyn M. Vickers, Leo Christopher DeRosier
Supplementary Table 1, Supplementary Figures 1-3 from TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008def6ec4f8a5ddd23a5cad1adbc6bd
https://doi.org/10.1158/1535-7163.22484012
https://doi.org/10.1158/1535-7163.22484012
Autor:
Donald J. Buchsbaum, Wenquan Wang, Tong Zhou, Li Nan, Hyunki Kim, Kurt R. Zinn, Albert F. LoBuglio, Patsy G. Oliver
Purpose: This study was designed to evaluate the in vitro cytotoxicity and in vivo efficacy of TRA-8, a mouse monoclonal antibody that binds to the DR5 death receptor for tumor necrosis factor–related apoptosis-inducing ligand (also called Apo2L),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc55ac0a366bc4004b8e8ba1dd716e0
https://doi.org/10.1158/1078-0432.c.6518289.v1
https://doi.org/10.1158/1078-0432.c.6518289.v1
Autor:
Donald J. Buchsbaum, Wenquan Wang, Tong Zhou, Li Nan, Hyunki Kim, Kurt R. Zinn, Albert F. LoBuglio, Patsy G. Oliver
Supplementary Figures S1-S4 from Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb8a69e190746b70893367cb61f78db
https://doi.org/10.1158/1078-0432.22441149
https://doi.org/10.1158/1078-0432.22441149
Autor:
James Turkson, Peibin Yue, Katherine E. Varley, Joy M. McDaniel, Stephanie L. Parker, Donald J. Buchsbaum, Bryan E. Welm, Katrin P. Guillen, Richard M. Myers, Patsy G. Oliver, Megan E. Conway, James M. Graham
Publikováno v:
Cancer Res
Breast cancers are divided into subtypes with different prognoses and treatment responses based on global differences in gene expression. Luminal breast cancer gene expression and proliferation are driven by estrogen receptor alpha, and targeting thi
Autor:
Donald J. Buchsbaum, Sumit Agarwal, Dafydd G. Thomas, Nirzari Gupta, Patsy G. Oliver, Isam-Eldin Eltoum, Hyung-Gyoon Kim, Sai Akshaya Hodigere Balasubramanya, Upender Manne, Kevin Hale, Sooryanarayana Varambally, Balabhadrapatruni V. S. K. Chakravarthi
Publikováno v:
Translational Oncology
Translational Oncology, Vol 13, Iss 7, Pp 100776-(2020)
Translational Oncology, Vol 13, Iss 7, Pp 100776-(2020)
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC progression that leads to aggressiveness of the di
Autor:
Rebecca C. Arend, Karina J. Yoon, Ronald D. Alvarez, Rebecca B. Vance, Patsy G. Oliver, Samuel C. Fehling, Charles N. Landen, Ashwini A. Katre, Kelly M. Kreitzburg, Robert C.A.M. van Waardenburg, Tracy L. Gamblin
Publikováno v:
Cancer Letters. 436:75-86
Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the United States. Although most patients respond to frontline therapy, virtually all patients relapse with chemoresistant disease. This study addresses the hypothesis